As of 2026-03-29, the Relative Valuation of PAVmed Inc (PAVM) is 44.82 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.67 USD, the upside of PAVmed Inc based on Relative Valuation is 416.9%.
The range of the Relative Valuation is 11.22 - 79.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.3x - 36.7x | 35.4x |
| Forward P/E multiples | 25.5x - 31.5x | 29.4x |
| Fair Price | 11.22 - 79.52 | 44.82 |
| Upside | 29.4% - 817.2% | 416.9% |
| Date | P/E |
| 2026-03-24 | 4.25 |
| 2026-03-23 | 4.54 |
| 2026-03-20 | 4.56 |
| 2026-03-19 | 4.48 |
| 2026-03-18 | 4.83 |
| 2026-03-17 | 4.80 |
| 2026-03-16 | 4.64 |
| 2026-03-13 | 4.71 |
| 2026-03-12 | 4.81 |
| 2026-03-11 | 4.96 |
| 2026-03-10 | 4.94 |
| 2026-03-09 | 4.90 |
| 2026-03-06 | 4.81 |
| 2026-03-05 | 4.81 |
| 2026-03-04 | 4.85 |
| 2026-03-03 | 4.69 |
| 2026-03-02 | 4.65 |
| 2026-02-27 | 4.66 |
| 2026-02-26 | 4.72 |
| 2026-02-25 | 4.80 |
| 2026-02-24 | 4.62 |
| 2026-02-23 | 4.24 |
| 2026-02-20 | 4.38 |
| 2026-02-19 | 4.33 |
| 2026-02-18 | 4.51 |
| 2026-02-17 | 4.75 |
| 2026-02-13 | 4.83 |
| 2026-02-12 | 4.75 |
| 2026-02-11 | 4.83 |
| 2026-02-10 | 5.06 |
| 2026-02-09 | 5.06 |
| 2026-02-06 | 4.99 |
| 2026-02-05 | 4.89 |
| 2026-02-04 | 4.74 |
| 2026-02-03 | 4.42 |
| 2026-02-02 | 4.32 |
| 2026-01-30 | 3.58 |
| 2026-01-29 | 3.53 |
| 2026-01-28 | 3.75 |
| 2026-01-27 | 4.00 |
| 2026-01-26 | 4.32 |
| 2026-01-23 | 4.23 |
| 2026-01-22 | 5.07 |
| 2026-01-21 | 5.57 |
| 2026-01-20 | 2.86 |
| 2026-01-16 | 3.04 |
| 2026-01-15 | 4.04 |
| 2026-01-14 | 4.25 |
| 2026-01-13 | 3.83 |
| 2026-01-12 | 3.76 |